Acoustic droplet vapourisation (ADV) and phase‐change contrast agents (PCCAs) represent a promising frontier in biomedical ultrasound technology. By employing focused ultrasound, liquid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback